BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31162673)

  • 1. Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation.
    Kong X; Wu G; Chen S; Zhang L; Li F; Shao T; Ren L; Chen SY; Zhang H; McClain CJ; Feng W
    Alcohol Clin Exp Res; 2019 Aug; 43(8):1662-1671. PubMed ID: 31162673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea polyphenols prevent lipopolysaccharide-induced inflammatory liver injury in mice by inhibiting NLRP3 inflammasome activation.
    Wang D; Zhang M; Wang T; Cai M; Qian F; Sun Y; Wang Y
    Food Funct; 2019 Jul; 10(7):3898-3908. PubMed ID: 31187838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective effect of allicin against acetaminophen-induced liver injury: Role of inflammasome pathway, apoptosis, and liver regeneration.
    Samra YA; Hamed MF; El-Sheakh AR
    J Biochem Mol Toxicol; 2020 May; 34(5):e22470. PubMed ID: 32040233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
    Zhang Z; Tian L; Jiang K
    Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ; Lee SM
    Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.
    He A; Shao J; Zhang Y; Lu H; Wu Z; Xu Y
    Oncotarget; 2017 May; 8(20):33214-33224. PubMed ID: 28402258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit.
    Flores-Costa R; Duran-Güell M; Casulleras M; López-Vicario C; Alcaraz-Quiles J; Diaz A; Lozano JJ; Titos E; Hall K; Sarno R; Masferrer JL; Clària J
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28263-28274. PubMed ID: 33106416
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang ZD; Zhang Y; Dai YD; Ren K; Han C; Wang HX; Yi SQ
    World J Gastroenterol; 2020 Mar; 26(12):1286-1297. PubMed ID: 32256017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Pan CW; Pan ZZ; Hu JJ; Chen WL; Zhou GY; Lin W; Jin LX; Xu CL
    Eur J Pharmacol; 2016 Jan; 770():85-91. PubMed ID: 26668000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-κB signaling.
    Li Q; Tan Y; Chen S; Xiao X; Zhang M; Wu Q; Dong M
    J Recept Signal Transduct Res; 2021 Jun; 41(3):294-303. PubMed ID: 32814473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AlCl
    Xu F; Ji Q; Zhang J; Huang W; Cao Z; Li Y
    Chemosphere; 2018 Oct; 209():972-980. PubMed ID: 30114748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes.
    Zhang F; Jin H; Wu L; Shao J; Wu X; Lu Y; Zheng S
    Biomed Pharmacother; 2016 Mar; 78():204-209. PubMed ID: 26898443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmine mitigates LPS-induced acute kidney injury through inhibition of the TLR4-NF-κB/NLRP3 inflammasome signalling pathway in mice.
    Niu X; Yao Q; Li W; Zang L; Li W; Zhao J; Liu F; Zhi W
    Eur J Pharmacol; 2019 Apr; 849():160-169. PubMed ID: 30716318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.